Norges Bank
ISEE

Norges Bank’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Norges Bank’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-955,130
Closed -$37.6M – 2063
2023
Q2 		$37.6M Buy
955,130
+686,544
+256% +$24.2M 0.01% 991
2023
Q1 		$6.53M Buy
268,586
+129,246
+93% +$2.83M ﹤0.01% 1689
2022
Q4 		$2.98M Buy
+139,340
New +$2.97M ﹤0.01% 1907
2017
Q2 		– Sell
-10,325
Closed -$38K – 2168
2017
Q1 		$38K Sell
10,325
-229,457
-96% -$970K ﹤0.01% 2136
2016
Q4 		$1.16M Hold
239,782
– – ﹤0.01% 2023
2016
Q3 		$10.6M Buy
239,782
+39,910
+20% +$2.25M 0.01% 1620
2016
Q2 		$10.2M Sell
199,872
-54,192
-21% -$2.69M ﹤0.01% 1599
2016
Q1 		$10.7M Buy
254,064
+35,777
+16% +$1.82M 0.01% 1523
2015
Q4 		$17.1M Hold
218,287
– – 0.01% 1261
2015
Q3 		$8.85M Buy
+218,287
New +$11.6M ﹤0.01% 1632

Norges Bank's ISEE Position: Q3 2023 in Review

Norges Bank sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 955,130 shares — an estimated $37.6M sold.

Norges Bank first reported a position in ISEE in Q3 2015 and held it in 10 quarters. The position peaked at $37.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Norges Bank reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Norges Bank sold 955,130 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $37.6M.
  • Norges Bank first reported a position in IVERIC bio, Inc. Common Stock in Q3 2015 and held it in 10 quarters.
  • Norges Bank's IVERIC bio, Inc. Common Stock position peaked at $37.6M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Norges Bank's 13F filing for Q3 2023, filed 13 Nov 2023.